173 related articles for article (PubMed ID: 25358399)
21. Regulation of gonadotropins by urocortin 2 in gonadotropic tumor LβT2 cells.
Kageyama K; Murasawa S; Niioka K; Otsuka F; Yagi H; Daimon M
Neurosci Lett; 2017 Nov; 660():63-67. PubMed ID: 28851616
[TBL] [Abstract][Full Text] [Related]
22. Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk.
Mahajan S; Liao M; Barkan P; Takahashi K; Bhargava A
Peptides; 2014 Apr; 54():58-66. PubMed ID: 24462512
[TBL] [Abstract][Full Text] [Related]
23. Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing.
Pilbrow AP; Lewis KA; Perrin MH; Sweet WE; Moravec CS; Tang WH; Huising MO; Troughton RW; Cameron VA
Endocrinology; 2016 Dec; 157(12):4865-4874. PubMed ID: 27754786
[TBL] [Abstract][Full Text] [Related]
24. Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes.
Dermitzaki E; Liapakis G; Androulidaki A; Venihaki M; Melissas J; Tsatsanis C; Margioris AN
PLoS One; 2014; 9(5):e97060. PubMed ID: 24835211
[TBL] [Abstract][Full Text] [Related]
25. Urocortin-dependent effects on adrenal morphology, growth, and expression of steroidogenic enzymes in vivo.
Riester A; Spyroglou A; Neufeld-Cohen A; Chen A; Beuschlein F
J Mol Endocrinol; 2012 Apr; 48(2):159-67. PubMed ID: 22312132
[TBL] [Abstract][Full Text] [Related]
26. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.
Tasma Z; Wills P; Hay DL; Walker CS
Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807
[TBL] [Abstract][Full Text] [Related]
27. Differential responses of corticotropin-releasing factor and urocortin 1 to acute pain stress in the rat brain.
Rouwette T; Klemann K; Gaszner B; Scheffer GJ; Roubos EW; Scheenen WJ; Vissers K; Kozicz T
Neuroscience; 2011 Jun; 183():15-24. PubMed ID: 21463663
[TBL] [Abstract][Full Text] [Related]
28. The calcineurin-nuclear factor of activated T cells signaling pathway mediates the effect of corticotropin releasing factor and urocortins on catecholamine synthesis.
Dermitzaki E; Tsatsanis C; Gravanis A; Margioris AN
J Cell Physiol; 2012 May; 227(5):1861-72. PubMed ID: 21702050
[TBL] [Abstract][Full Text] [Related]
29. The corticotropin-releasing factor (CRF) family of peptides as local modulators of adrenal function.
Tsatsanis C; Dermitzaki E; Venihaki M; Chatzaki E; Minas V; Gravanis A; Margioris AN
Cell Mol Life Sci; 2007 Jul; 64(13):1638-55. PubMed ID: 17453142
[TBL] [Abstract][Full Text] [Related]
30. Hypothalamic expression of urocortin 3 and the type 2 corticotropin-releasing factor receptor is regulated according to feeding state in lean but not obese Zucker rats.
Poulin AM; Lenglos C; Mitra A; Timofeeva E
Neuropharmacology; 2012 Jul; 63(1):147-53. PubMed ID: 22227020
[TBL] [Abstract][Full Text] [Related]
31. Involvement of Nurr-1/Nur77 in corticotropin-releasing factor/urocortin1-induced tyrosinase-related protein 1 gene transcription in human melanoma HMV-II cells.
Watanuki Y; Takayasu S; Kageyama K; Iwasaki Y; Sakihara S; Terui K; Nigawara T; Suda T
Mol Cell Endocrinol; 2013 May; 370(1-2):42-51. PubMed ID: 23416839
[TBL] [Abstract][Full Text] [Related]
32. Corticotropin releasing factor-distribution in rat intestine and role in neuroprotection.
Sand E; Themner-Persson A; Ekblad E
Regul Pept; 2011 Jan; 166(1-3):68-75. PubMed ID: 20801165
[TBL] [Abstract][Full Text] [Related]
33. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
Henry BA; Lightman SL; Lowry CA
J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765
[TBL] [Abstract][Full Text] [Related]
34. Possible involvement of corticotropin-releasing factor receptor signaling on vascular inflammation.
Inada Y; Ikeda K; Tojo K; Sakamoto M; Takada Y; Tajima N
Peptides; 2009 Feb; 30(2):365-72. PubMed ID: 19026699
[TBL] [Abstract][Full Text] [Related]
35. Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect.
Yuan PQ; Wu SV; Pothoulakis C; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G387-98. PubMed ID: 26744472
[TBL] [Abstract][Full Text] [Related]
36. Ucn3 and CRF-R2 in the medial amygdala regulate complex social dynamics.
Shemesh Y; Forkosh O; Mahn M; Anpilov S; Sztainberg Y; Manashirov S; Shlapobersky T; Elliott E; Tabouy L; Ezra G; Adler ES; Ben-Efraim YJ; Gil S; Kuperman Y; Haramati S; Dine J; Eder M; Deussing JM; Schneidman E; Yizhar O; Chen A
Nat Neurosci; 2016 Nov; 19(11):1489-1496. PubMed ID: 27428651
[TBL] [Abstract][Full Text] [Related]
37. The suppression effects of feeding and mechanisms in CRF system of animals.
Qi J; Zhang X; Li Y; Xu S; Wang M; Chen H; Tang N; Wang S; Wang B; Chen D; Zhou B; Li Z
Gene; 2020 Apr; 733():144363. PubMed ID: 31935510
[TBL] [Abstract][Full Text] [Related]
38. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
Porcher C; Juhem A; Peinnequin A; Sinniger V; Bonaz B
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181
[TBL] [Abstract][Full Text] [Related]
39. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
